Aulos Bioscience to Present Phase 2 Data for Imneskibart With Avelumab in Adenocarcinoma Non — Small Cell Lung Cancer at ESMO Congress 2026
For best results when printing this announcement, please click on link below: Aulos Bioscience to Present Phase 2 Data for Imneskibart With Avelumab in Adenocarcinoma Non-Small Cell Lung Cancer at ESMO Congress 2026 Aulos( )Bioscience, an immuno-oncology company working to revolutionize cancer care through development